BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17657678)

  • 41. Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infection.
    Zhang HY; Nanji AA; Luk JM; Huang XR; Lo CM; Chen YX; Yuen ST; Lan HY; Lau GK
    Liver Int; 2005 Jun; 25(3):571-9. PubMed ID: 15910495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Macrophage migration inhibitory factor expression in ovarian cancer.
    Agarwal R; Whang DH; Alvero AB; Visintin I; Lai Y; Segal EA; Schwartz P; Ward D; Rutherford T; Mor G
    Am J Obstet Gynecol; 2007 Apr; 196(4):348.e1-5. PubMed ID: 17403417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseases.
    Kibiki GS; van der Ven AJ; Geurts-Moespot A; Shao J; Calandra T; Sweep FC; Dolmans WM
    Clin Immunol; 2007 Apr; 123(1):60-5. PubMed ID: 17275414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.
    Nicoletti F; Créange A; Orlikowski D; Bolgert F; Mangano K; Metz C; Di Marco R; Al Abed Y
    J Neuroimmunol; 2005 Nov; 168(1-2):168-74. PubMed ID: 16171874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis.
    Rahman SH; Menon KV; Holmfield JH; McMahon MJ; Guillou JP
    Ann Surg; 2007 Feb; 245(2):282-9. PubMed ID: 17245183
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas.
    Lee H; Rhee H; Kang HJ; Kim HS; Min BS; Kim NK; Kim H
    Am J Clin Pathol; 2008 May; 129(5):772-9. PubMed ID: 18426738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunologic abnormalities in children with acute Kawasaki disease.
    Ding XT; Yang XQ; Li CR; Shen J
    Chin Med J (Engl); 1993 Sep; 106(9):688-92. PubMed ID: 8287706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis.
    Shimizu T; Abe R; Ohkawara A; Mizue Y; Nishihira J
    Biochem Biophys Res Commun; 1997 Nov; 240(1):173-8. PubMed ID: 9367905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma.
    Khan N; Cromer CJ; Campa M; Patz EF
    Cancer; 2004 Jul; 101(2):379-84. PubMed ID: 15241837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF).
    Aloisi AM; Pari G; Ceccarelli I; Vecchi I; Ietta F; Lodi L; Paulesu L
    Pain; 2005 May; 115(1-2):142-51. PubMed ID: 15836977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease.
    Maury CP; Salo E; Pelkonen P
    J Lab Clin Med; 1989 May; 113(5):651-4. PubMed ID: 2715685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of macrophage migration inhibitory factor in paranasal sinus mucocele.
    Kariya S; Okano M; Aoji K; Nakashima T; Kasai N; Onoda T; Nishizaki K; Schachern PA; Cureoglu S; Paparella MM
    Am J Rhinol; 2005; 19(6):554-9. PubMed ID: 16402640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China.
    Wu J; Chen F; Zhang X; Li Y; Ma H; Zhou Y; Jin Y; Wang H; Bai J; Zhang G; Fu S
    J Dermatol Sci; 2009 Mar; 53(3):212-5. PubMed ID: 19157791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
    Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
    Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum levels of interleukin-18 are elevated in the subacute phase of kawasaki syndrome.
    Nomura Y; Masuda K; Maeno N; Yoshinaga M; Kawano Y
    Int Arch Allergy Immunol; 2004 Oct; 135(2):161-5. PubMed ID: 15345916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease.
    Hirono K; Foell D; Xing Y; Miyagawa-Tomita S; Ye F; Ahlmann M; Vogl T; Futatani T; Rui C; Yu X; Watanabe K; Wanatabe S; Tsubata S; Uese K; Hashimoto I; Ichida F; Nakazawa M; Roth J; Miyawaki T
    J Am Coll Cardiol; 2006 Sep; 48(6):1257-64. PubMed ID: 16979015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macrophage migration inhibitory factor is increased in the urine of patients with urinary tract infection: macrophage migration inhibitory factor-protein complexes in human urine.
    Meyer-Siegler KL; Iczkowski KA; Vera PL
    J Urol; 2006 Apr; 175(4):1523-8. PubMed ID: 16516040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of dexamethasone on macrophage migration inhibitory factor production in sepsis.
    Bruhn A; Verdant C; Vercruysse V; Su F; Vray B; Vincent JL
    Shock; 2006 Aug; 26(2):169-73. PubMed ID: 16878025
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Macrophage migration inhibition factor is elevated in pregnancy, but not to a greater extent in preeclampsia.
    Hristoskova S; Holzgreve W; Zhong XY; Hahn S
    Arch Gynecol Obstet; 2006 Apr; 274(1):25-8. PubMed ID: 16369812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum interleukin-6 in Kawasaki disease.
    Kim DS
    Yonsei Med J; 1992 Jun; 33(2):183-8. PubMed ID: 1413896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.